These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 26553744)

  • 1. Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome.
    Eisenberg MJ; Windle SB; Roy N; Old W; Grondin FR; Bata I; Iskander A; Lauzon C; Srivastava N; Clarke A; Cassavar D; Dion D; Haught H; Mehta SR; Baril JF; Lambert C; Madan M; Abramson BL; Dehghani P;
    Circulation; 2016 Jan; 133(1):21-30. PubMed ID: 26553744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking abstinence 1 year after acute coronary syndrome: follow-up from a randomized controlled trial of varenicline in patients admitted to hospital.
    Windle SB; Dehghani P; Roy N; Old W; Grondin FR; Bata I; Iskander A; Lauzon C; Srivastava N; Clarke A; Cassavar D; Dion D; Haught H; Mehta SR; Baril JF; Lambert C; Madan M; Abramson BL; Eisenberg MJ;
    CMAJ; 2018 Mar; 190(12):E347-E354. PubMed ID: 29581161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of the efficacy and safety of varenicline for smoking cessation after acute coronary syndrome: design and methods of the Evaluation of Varenicline in Smoking Cessation for Patients Post-Acute Coronary Syndrome trial.
    Windle SB; Bata I; Madan M; Abramson BL; Eisenberg MJ
    Am Heart J; 2015 Oct; 170(4):635-640.e1. PubMed ID: 26386786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.
    Bolliger CT; Issa JS; Posadas-Valay R; Safwat T; Abreu P; Correia EA; Park PW; Chopra P
    Clin Ther; 2011 Apr; 33(4):465-77. PubMed ID: 21635992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: a randomized, placebo-controlled trial.
    Eisenberg MJ; Grandi SM; Gervais A; O'Loughlin J; Paradis G; Rinfret S; Sarrafzadegan N; Sharma S; Lauzon C; Yadav R; Pilote L;
    J Am Coll Cardiol; 2013 Feb; 61(5):524-32. PubMed ID: 23369417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
    Williams JM; Anthenelli RM; Morris CD; Treadow J; Thompson JR; Yunis C; George TP
    J Clin Psychiatry; 2012 May; 73(5):654-60. PubMed ID: 22697191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smokers and Postcessation Weight Gain After Acute Coronary Syndrome.
    Dehghani P; Habib B; Windle SB; Roy N; Old W; Grondin FR; Bata I; Iskander A; Lauzon C; Srivastava N; Clarke A; Cassavar D; Dion D; Haught H; Mehta SR; Baril JF; Lambert C; Madan M; Abramson BL; Eisenberg MJ
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28420644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
    Tonstad S; Tønnesen P; Hajek P; Williams KE; Billing CB; Reeves KR;
    JAMA; 2006 Jul; 296(1):64-71. PubMed ID: 16820548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Chengappa KN; Perkins KA; Brar JS; Schlicht PJ; Turkin SR; Hetrick ML; Levine MD; George TP
    J Clin Psychiatry; 2014 Jul; 75(7):765-72. PubMed ID: 25006684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.
    Tsai ST; Cho HJ; Cheng HS; Kim CH; Hsueh KC; Billing CB; Williams KE
    Clin Ther; 2007 Jun; 29(6):1027-39. PubMed ID: 17692719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial.
    Ebbert JO; Hughes JR; West RJ; Rennard SI; Russ C; McRae TD; Treadow J; Yu CR; Dutro MP; Park PW
    JAMA; 2015 Feb; 313(7):687-94. PubMed ID: 25688780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline for smoking cessation: a placebo-controlled, randomized study.
    Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S
    Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varenicline versus placebo for waterpipe smoking cessation: a double-blind randomized controlled trial.
    Dogar O; Zahid R; Mansoor S; Kanaan M; Ahluwalia JS; Jawad M; Siddiqi K
    Addiction; 2018 Dec; 113(12):2290-2299. PubMed ID: 30187978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.
    Evins AE; Cather C; Pratt SA; Pachas GN; Hoeppner SS; Goff DC; Achtyes ED; Ayer D; Schoenfeld DA
    JAMA; 2014 Jan; 311(2):145-54. PubMed ID: 24399553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACP Journal Club. Varenicline increased smoking cessation at 24 weeks in patients hospitalized with ACS and motivated to quit.
    Prochazka AV
    Ann Intern Med; 2016 Apr; 164(8):JC43. PubMed ID: 27089092
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Varenicline Added to Counseling on Smoking Cessation Among African American Daily Smokers: The Kick It at Swope IV Randomized Clinical Trial.
    Cox LS; Nollen NL; Mayo MS; Faseru B; Greiner A; Ellerbeck EF; Krebill R; Tyndale RF; Benowitz NL; Ahluwalia JS
    JAMA; 2022 Jun; 327(22):2201-2209. PubMed ID: 35699705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco dependence treatment for hospitalized smokers: a randomized, controlled, pilot trial using varenicline.
    Steinberg MB; Randall J; Greenhaus S; Schmelzer AC; Richardson DL; Carson JL
    Addict Behav; 2011 Dec; 36(12):1127-32. PubMed ID: 21835552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    Russo C; Walicka M; Caponnetto P; Cibella F; Maglia M; Alamo A; Campagna D; Frittitta L; Di Mauro M; Caci G; Krysinski A; Franek E; Polosa R
    JAMA Netw Open; 2022 Jun; 5(6):e2217709. PubMed ID: 35727580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.